Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant HEATON k.s., against the decision of the State Institute for Drug Control from 14. 9. 2021, under the no: SUKLS21356/2021:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Gedeon Richter Plc., against the decision of the State Institute for Drug Control from 29. 9. 2021, under the no: SUKLS207303/2021:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Accord Healthcare Polska Sp. z o.o., against the decision of the State Institute for Drug Control from 29. 9. 2021, under the no: SUKLS281382/2020:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant MEDREG s.r.o., against the decision of the State Institute for Drug Control from 30. 9. 2021, under the no: SUKLS276968/2020:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant ARDEAPHARMA, a.s., against the decision of the State Institute for Drug Control from  6. 10. 2021, under the no: SUKLS36300/2021:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelants Dr. Falk Pharma GmbH and Ferring-Léčiva, a.s., against the decision of the State Institute for Drug Control from 11. 10. 2021, under the no: SUKLS174248/2020:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant HRA Pharma Rare Diseases, against the decision of the State Institute for Drug Control from 14. 10. 2021, under the no: SUKLS34108/2021:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Egis Pharmaceuticals PLC, against the decision of the State Institute for Drug Control from 9. 9. 2020, under the no: SUKLS109905/2020:

• the decision is reversed and the proceedings are terminated.

More information: MZCR.cz.